Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consent and liability: special problems with anxiolytics.

M J Mills1, S Eth

  • 1Department of Psychiatry and Biobehavioral Sciences, School of Medicine, University of California, Los Angeles.

The Journal of Clinical Psychiatry
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the origin of extraordinary cyclic strengthening of the austenitic stainless steel Sanicro 25 during fatigue at 700°C.

Journal of materials research·2020
Same author

Dynamical scattering image simulations for two-phase γ-γ' microstructures: A theoretical model.

Ultramicroscopy·2017
Same author

Phase transformation strengthening of high-temperature superalloys.

Nature communications·2016
Same author

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Leukemia & lymphoma·2016
Same author

Behavioral family therapy for Vietnam combat veterans with posttraumatic stress disorder.

The Journal of psychotherapy practice and research·2012
Same author

Diffraction contrast STEM of dislocations: imaging and simulations.

Ultramicroscopy·2011
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Physicians must warn patients about benzodiazepine risks like addiction and cognitive impairment. Exploring safer alternatives and informed consent is crucial for avoiding liability in anxiolytic therapy.

Area of Science:

  • Pharmacology
  • Medical Ethics
  • Legal Medicine

Background:

  • Benzodiazepine anxiolytic therapy is associated with adverse reactions, including addiction, withdrawal, and impaired cognitive/motor skills.
  • Newer anxiolytics like buspirone offer alternatives with potentially fewer side effects and lower addiction potential.
  • Clinician responsibility in managing patient expectations and risks associated with anxiolytic prescriptions is a significant concern.

Purpose of the Study:

  • To examine the extent of clinician responsibility in warning patients about benzodiazepine therapy risks.
  • To discuss the implications of alternative anxiolytics on treatment decisions and physician obligations.
  • To review legal precedents concerning benzodiazepine-induced impairment and its impact on medical practice.

Main Methods:

Related Experiment Videos

  • Literature review of adverse reactions associated with benzodiazepine anxiolytic therapy.
  • Analysis of legal cases involving benzodiazepine-induced driving impairment.
  • Discussion of ethical considerations regarding informed consent and physician liability.

Main Results:

  • Benzodiazepine therapy carries risks of addiction, withdrawal, and cognitive/motor impairment, necessitating patient warnings.
  • Alternative anxiolytics like buspirone may reduce these risks, presenting a treatment option.
  • Informed consent, clear documentation, and individualized treatment are key to mitigating physician liability.

Conclusions:

  • Clinicians have a responsibility to inform patients about the potential adverse effects of benzodiazepines.
  • The availability of alternative anxiolytics raises questions about the obligation to prescribe agents with the least impairment.
  • Prioritizing quality care, informed consent, and thorough documentation is essential for responsible anxiolytic prescription and liability avoidance.